Kelley Kendle

Biography

Ms. Kendle is the President of Certara’s Synchrogenix regulatory strategy, science, and services business. Over her 15-year career at Synchrogenix, Ms. Kendle served as the key driver of the vision and explosive growth of the Company. In her early roles in Operations, Finance, and Business Development, she grew Synchrogenix into the largest Regulatory Writing company in the world. In her leadership role, Ms. Kendle not only grew Synchrogenix organically, but acquired two companies, ClinGenuity and Global Submit. The ClinGenuity acquisition provided a unique artificial intelligence, natural language processing technology that automates first drafts of regulatory documents and redacts private and personal information with high quality and efficiency. Global Submit provides a SaaS suite of solutions to efficiently publish, validate, and review eCTD submissions and manage the bolus of required regulatory information. Synchrogenix was named Best Place to Work on multiple occasions, and on the INC 5000 list of fast growing privately held companies for the past five years.

Research Interest

Bioinformatics and system biology